AI assistant
Sending…
Summit Therapeutics Inc. — Director's Dealing 2022
Oct 3, 2022
30436_dirs_2022-10-03_6562cae7-3727-4d2f-baa6-bd6c3ba464a6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Summit Therapeutics Inc. (SMMT)
CIK: 0001599298
Period of Report: 2022-09-28
Reporting Person: Booth Robert F. (Director)
More from Summit Therapeutics Inc.
Regulatory Filings
2026
Jun 1
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 17
Annual Report
2026
Feb 23
Regulatory Filings
2026
Feb 23
Regulatory Filings
2026
Jan 29
Director's Dealing
2026
Jan 12
Regulatory Filings
2026
Jan 12
Director's Dealing
2026
Jan 7
Director's Dealing
2026
Jan 7